NUTEX Investments Past Earnings Performance
Past criteria checks 4/6
NUTEX Investments has been growing earnings at an average annual rate of 76.4%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 0% per year. NUTEX Investments's return on equity is 8.1%, and it has net margins of 103075.6%.
Key information
76.4%
Earnings growth rate
71.6%
EPS growth rate
| Pharmaceuticals Industry Growth | 12.4% |
| Revenue growth rate | 0% |
| Return on equity | 8.1% |
| Net Margin | 103,075.6% |
| Last Earnings Update | 30 Jun 2024 |
Revenue & Expenses Breakdown
How NUTEX Investments makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 0 | 464 | 19 | 0 |
| 31 Mar 24 | 0 | 317 | 20 | 0 |
| 31 Dec 23 | 0 | 171 | 21 | 0 |
| 30 Sep 23 | 0 | 121 | 21 | 0 |
| 30 Jun 23 | 0 | 71 | 21 | 0 |
| 31 Mar 23 | 0 | 101 | 19 | 0 |
| 31 Dec 22 | 0 | 131 | 16 | 0 |
| 30 Sep 22 | 0 | 115 | 15 | 0 |
| 30 Jun 22 | 0 | 99 | 14 | 0 |
| 31 Mar 22 | 0 | 56 | 14 | 0 |
| 31 Dec 21 | 0 | 13 | 13 | 0 |
| 30 Sep 21 | 0 | -10 | 14 | 0 |
| 30 Jun 21 | 0 | -32 | 14 | 0 |
| 31 Mar 21 | 0 | -3 | 16 | 0 |
| 31 Dec 20 | 0 | 26 | 19 | 0 |
| 30 Sep 20 | 0 | 15 | 18 | 0 |
| 30 Jun 20 | 0 | 4 | 18 | 0 |
| 31 Mar 20 | 0 | -2 | 14 | 0 |
| 31 Dec 19 | 1 | -8 | 10 | 0 |
Quality Earnings: NUTEX has a high level of non-cash earnings.
Growing Profit Margin: NUTEX's current net profit margins are higher than last year .
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: NUTEX's earnings have grown significantly by 76.4% per year over the past 5 years.
Accelerating Growth: NUTEX's earnings growth over the past year (556.1%) exceeds its 5-year average (76.4% per year).
Earnings vs Industry: NUTEX earnings growth over the past year (556.1%) exceeded the Pharmaceuticals industry 8.9%.
Return on Equity
High ROE: NUTEX's Return on Equity (8.1%) is considered low.